Brief: Clovis Oncology Q2 Loss Per Share $0.50
08/08/2022 13:22
Aug 8 (Reuters) - Clovis Oncology Inc CLVS.O :
* CLOVIS ONCOLOGY ANNOUNCES SECOND QUARTER 2022 OPERATING
RESULTS
AND PROVIDES UPDATE ON CLINICAL DEVELOPMENT PROGRAMS
* Q2 LOSS PER SHARE $0.50
* QTRLY PRODUCT REVENUES $32.1 MILLION VERSUS $36.8 MILLION
Source text for Eikon: ID:nBw2ywR3da
Further company coverage: CLVS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clovis Oncology
See all newsBrief: Clovis Oncology Inc - On April 5, 2023, Entered Into Asset Purchase Agreement With Pharma& To Sell Product Business For Upfront Payment Of $70 Million
Brief: Clovis Oncology Enters Into Financing Agreement
Brief: Clovis Oncology Inc Received Written Notice From Nasdaq That Company's Common Stock Will Be Delisted From Nasdaq
U.S. STOCKS ON THE MOVE-Nike, Faraday Future, PBF Energy
U.S. STOCKS ON THE MOVE-Natural gas, Box Inc, Weber